QLGN
Price:
$3.21
Market Cap:
$7.53M
Qualigen Therapeutics, Inc. is a biotechnology enterprise focused on advancing groundbreaking treatments for both cancer and infectious diseases. In addition to its developmental pipeline, the company offers FastPack, an efficient system designed for swift diagnostic testing. Its therapeutic candidates currently undergoing development include QN-302, an investigational compound targeting pancreatic ductal adenocarcinoma; QN-247, a DNA-coated gold nanoparticle formulated to combat various types of cancer; and RAS-F, a small-molecule inhibitor designed to block RAS oncogene protein-protein interactions, thereby impeding RAS mutations and suppressing tumor growth. The company is also progressin...[Read more]
Industry
Biotechnology
IPO Date
2015-06-23
Stock Exchange
NASDAQ
Ticker
QLGN
According to Qualigen Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 1.13. This represents a change of -363.59% compared to the average of -0.43 of the last 4 quarters.
The mean historical PE Ratio of Qualigen Therapeutics, Inc. over the last ten years is -114.79. The current 1.13 PE Ratio has changed -198.12% with respect to the historical average. Over the past ten years (40 quarters), QLGN's PE Ratio was at its highest in in the December 2020 quarter at 2.48. The PE Ratio was at its lowest in in the March 2019 quarter at -60.67.
Average
-114.79
Median
-0.81
Minimum
-1029.55
Maximum
-0.16
Discovering the peaks and valleys of Qualigen Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 77.40%
Maximum Annual PE Ratio = -0.16
Minimum Annual Increase = -99.86%
Minimum Annual PE Ratio = -1029.55
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -0.29 | 20.28% |
| 2024 | -0.24 | 14.53% |
| 2023 | -0.21 | -21.03% |
| 2022 | -0.27 | -84.88% |
| 2021 | -1.75 | -17.79% |
| 2020 | -2.13 | 1.24% |
| 2019 | -0.16 | -99.86% |
| 2019 | -112.00 | -89.12% |
| 2018 | -1029.55 | 77.40% |
| 2016 | -1.33 | 143.02% |
The current PE Ratio of Qualigen Therapeutics, Inc. (QLGN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-0.25
5-year avg
-0.55
10-year avg
-114.79
Qualigen Therapeutics, Inc.’s PE Ratio is greater than Soligenix, Inc. (-0.20), greater than Oragenics, Inc. (-0.09), less than Titan Pharmaceuticals, Inc. (13.82), greater than Can-Fite BioPharma Ltd. (-686.14), greater than Xenetic Biosciences, Inc. (-2.28), greater than Kazia Therapeutics Limited (-1.91), greater than Ensysce Biosciences, Inc. (-0.08), greater than CNS Pharmaceuticals, Inc. (-0.16), greater than Clearmind Medicine Inc. (-0.27), greater than KALA BIO, Inc. (-1.25),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.20 | $4.12M | |
| -0.09 | $2.48M | |
| 13.82 | $3.11M | |
| -686.14 | $1.60M | |
| -2.28 | $5.29M | |
| -1.91 | $22.45M | |
| -0.08 | $2.52M | |
| -0.16 | $2.70M | |
| -0.27 | $3.13M | |
| -1.25 | $79.17M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Qualigen Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Qualigen Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Qualigen Therapeutics, Inc.'s PE Ratio?
How is the PE Ratio calculated for Qualigen Therapeutics, Inc. (QLGN)?
What is the highest PE Ratio for Qualigen Therapeutics, Inc. (QLGN)?
What is the 3-year average PE Ratio for Qualigen Therapeutics, Inc. (QLGN)?
What is the 5-year average PE Ratio for Qualigen Therapeutics, Inc. (QLGN)?
How does the current PE Ratio for Qualigen Therapeutics, Inc. (QLGN) compare to its historical average?